These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38033615)

  • 1. Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident stroke.
    Sperber PS; Gebert P; Broersen LHA; Kufner A; Huo S; Piper SK; Teegen B; Heuschmann PU; Prüss H; Endres M; Liman TG; Siegerink B
    Brain Behav Immun Health; 2023 Dec; 34():100705. PubMed ID: 38033615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-NMDA-receptor antibodies and cognitive function after ischemic stroke (PROSCIS-B).
    Sperber PS; Gebert P; Broersen LHA; Huo S; Piper SK; Teegen B; Heuschmann PU; Prüss H; Endres M; Liman TG; Siegerink B
    J Neurol; 2022 Oct; 269(10):5521-5530. PubMed ID: 35718820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B).
    Sperber PS; Siegerink B; Huo S; Rohmann JL; Piper SK; Prüss H; Heuschmann PU; Endres M; Liman TG
    Stroke; 2019 Nov; 50(11):3213-3219. PubMed ID: 31526121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke.
    Deutsch NR; Worthmann H; Steixner-Kumar AA; Schuppner R; Grosse GM; Pan H; Gabriel MM; Hasse I; van Gemmeren T; Lichtinghagen R; Ehrenreich H; Weissenborn K
    Brain Behav Immun; 2021 Aug; 96():73-79. PubMed ID: 34010714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of C-reactive protein with depressive symptoms over time after mild to moderate ischemic stroke in the PROSCIS-B cohort.
    Schaeff VLK; Sperber PS; Piper SK; Giesers NK; Gertz K; Heuschmann PU; Endres M; Liman TG
    J Neurol; 2024 Feb; 271(2):909-917. PubMed ID: 37848651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.
    Pearlman DM; Najjar S
    Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low ankle-brachial index and cognitive function after stroke-the PROSpective with Incident Stroke Berlin (PROSCIS-B).
    Stillfried MRV; Sperber PS; Broersen LHA; Huo S; Piper SK; Heuschmann PU; Endres M; Siegerink B; Liman TG
    Front Neurol; 2022; 13():963262. PubMed ID: 36247749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease.
    Ehrenreich H
    Curr Opin Neurol; 2018 Jun; 31(3):306-312. PubMed ID: 29474316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
    Zerche M; Weissenborn K; Ott C; Dere E; Asif AR; Worthmann H; Hassouna I; Rentzsch K; Tryc AB; Dahm L; Steiner J; Binder L; Wiltfang J; Sirén AL; Stöcker W; Ehrenreich H
    Stroke; 2015 May; 46(5):1180-6. PubMed ID: 25765725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.
    Ando Y; Shimazaki H; Shiota K; Tetsuka S; Nakao K; Shimada T; Kurata K; Kuroda J; Yamashita A; Sato H; Sato M; Eto S; Onishi Y; Tanaka K; Kato S
    BMC Psychiatry; 2016 Jul; 16():226. PubMed ID: 27391811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis.
    Ciano-Petersen NL; Robert M; Muñiz-Castrillo S; Wucher V; Klich A; Vogrig A; Villagrán García M; Farina A; Goncalves D; Picard G; Rogemond V; Joubert B; Oliver-Martos B; Serrano-Castro PJ; Maucort-Boulch D; Honnorat J
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37147137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up.
    Xu CL; Liu L; Zhao WQ; Li JM; Wang RJ; Wang SH; Wang DX; Liu MY; Qiao SS; Wang JW
    BMC Neurol; 2011 Nov; 11():149. PubMed ID: 22126669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
    Hara M; Martinez-Hernandez E; Ariño H; Armangué T; Spatola M; Petit-Pedrol M; Saiz A; Rosenfeld MR; Graus F; Dalmau J
    Neurology; 2018 Apr; 90(16):e1386-e1394. PubMed ID: 29549218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
    Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
    JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model.
    Pan H; Oliveira B; Saher G; Dere E; Tapken D; Mitjans M; Seidel J; Wesolowski J; Wakhloo D; Klein-Schmidt C; Ronnenberg A; Schwabe K; Trippe R; Mätz-Rensing K; Berghoff S; Al-Krinawe Y; Martens H; Begemann M; Stöcker W; Kaup FJ; Mischke R; Boretius S; Nave KA; Krauss JK; Hollmann M; Lühder F; Ehrenreich H
    Mol Psychiatry; 2019 Oct; 24(10):1489-1501. PubMed ID: 29426955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies.
    Roggen EL; Hoofd G; Van Dyck E; Piot P
    Sex Transm Dis; 1994; 21(1):36-42. PubMed ID: 8140487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias.
    Busse S; Brix B; Kunschmann R; Bogerts B; Stoecker W; Busse M
    Neurosci Res; 2014 Aug; 85():58-64. PubMed ID: 24973618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury.
    Pan H; Steixner-Kumar AA; Seelbach A; Deutsch N; Ronnenberg A; Tapken D; von Ahsen N; Mitjans M; Worthmann H; Trippe R; Klein-Schmidt C; Schopf N; Rentzsch K; Begemann M; Wienands J; Stöcker W; Weissenborn K; Hollmann M; Nave KA; Lühder F; Ehrenreich H
    Mol Psychiatry; 2021 Jun; 26(6):2471-2482. PubMed ID: 32089545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against the
    Ehrenreich H
    Front Immunol; 2017; 8():181. PubMed ID: 28298911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology.
    Dubey D; Alqallaf A; Hays R; Freeman M; Chen K; Ding K; Agostini M; Vernino S
    JAMA Neurol; 2017 Apr; 74(4):397-402. PubMed ID: 28166327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.